Renaissance Technologies
TARS icon

Renaissance Technologies’s Tarsus Pharmaceuticals TARS Stock Holding History

Renaissance Technologies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.15M Buy
73,400
+9,300
+15% +$650K 0.01% 1366
2025
Q4 		$5.25M Buy
64,100
+22,500
+54% +$1.68M 0.01% 1275
2025
Q3 		$2.47M Buy
+41,600
New +$2.05M ﹤0.01% 1930
2023
Q4 		– Sell
-106,900
Closed -$1.9M – 4124
2023
Q3 		$1.9M Sell
106,900
-7,600
-7% -$134K ﹤0.01% 1900
2023
Q2 		$2.07M Buy
114,500
+40,500
+55% +$644K ﹤0.01% 1975
2023
Q1 		$930K Buy
74,000
+8,400
+13% +$123K ﹤0.01% 2524
2022
Q4 		$962K Sell
65,600
-3,900
-6% -$64.5K ﹤0.01% 2557
2022
Q3 		$1.19M Buy
69,500
+9,200
+15% +$146K ﹤0.01% 2390
2022
Q2 		$880K Buy
+60,300
New +$905K ﹤0.01% 2798

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return